>> 全站文章索引 >> 第24页:
  • Effect of SB-243213, a selective 5-HT2C receptor antagonist, on the rat sleep profile: A comparison to paroxetine - [M. I. Smith, D. C. Piper, M. S. Duxon and N. Upton]
  • A Pilot Trial of Paroxetine for the Treatment of Hot Flashes and Associated Symptoms in Women with Breast Cancer - [Michael A. Weitzner, Joanne Moncello, Paul B. Jacobsen and Susan Minton]
  • Intent-to-treat analysis for clinical trials: use of data collected after termination of treatment protocol - [Sati Mazumdar, Patricia R. Houck, Kenneth S. Liu, Benoit H. Mulsant, Bruce G. Pol1ock, Mary Amanda Dew and Charles F. Reynolds III]
  • Molecular characterisation of antidepressant effects in the mouse brain using gene expression profiling - [J. Landgrebe, G. Welzl, T. Metz, M. M. van Gaalen, H. Ropers, W. Wurst and F. Holsboer]
  • EEG correlates of acute and chronic paroxetine treatment in depression - [Verner Knott, Colleen Mahoney, Sidney Kennedy and Kenneth Evans]
  • Course and rate of antidepressant response in the very old - [Ariel G. Gildengers, Patricia R. Houck, Benoit H. Mulsant, Bruce G. Pollock, Sati Mazumdar, Mark D. Miller, Mary Amanda Dew, Ellen Frank, David J. Kupfer and Charles F. Reynolds III]
  • How well do antidepressants work in older people? A systematic review of Number Needed to Treat - [.]
  • Effect of treatment of panic disorder in patients with frequent ICD discharges: a pilot study - [P. M. J. C. Kuijpers, A. Honig and H. J. J. Wellens]
  • Improved efficacy of fluoxetine in increasing hippocampal 5-hydroxytryptamine outflow in 5-HT1B receptor knock-out mice - [Isabelle Malagié, Denis J. David, Pascale Jolliet, René Hen, Michel Bourin and Alain M. Gardier]
  • Differential effects of chronic antidepressant treatments on μ- and δ-opioid receptors in rat brain - [Catherine Vilpoux, Céline Carpentier, Isabelle Leroux-Nicollet, Laurent Naudon and Jean Costentin]
  • Penetrating the blind in a study of an SSRI - [Melissa P. Piasecki, David O. Antonuccio, Gerri M. Steinagel, Barbara S. Kohlenberg and Karen Kapadar]
  • Serotonin, 5-hydroxyindoleacetic acid and serotonin transporter in blood peripheral lymphocytes of patients with generalized anxiety disorder - [E. Hernández, S. Lastra, M. Urbina, I. Carreira and L. Lima]
  • Acute effects of amperozide and paroxetine on social cohesion in male conspecifics - [David J. Rademacher, Anthony P. Anderson and Rhea E. Steinpreis]
  • Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography - [L. Labat, M. Deveaux, P. Dallet and J. P. Dubost]
  • Reduced (±)-3,4-methylenedioxymethamphetamine (“Ecstasy”) metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro - [Yamini Ramamoorthy, Ai-ming Yu, Nina Suh, Robert L. Haining, Rachel F. Tyndale and Edward M. Sellers]
  • Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative - [Feng C. Zhou, Klaus-Peter Lesch and Dennis L. Murphy]
  • Aging alters in a region-specific manner serotonin transporter sites and 5-HT1A receptor-G protein interactions in hamster brain - [Marilyn J. Duncan and Julie G. Hensler]
  • Predicting treatment-outcome in cocaine dependence from admission urine drug screen and peripheral serotonergic measures - [Ashwin A. Patkar, Charles C. Thornton, Wade H. Berrettini, Edward Gottheil, Stephen P. Weinstein and Kevin P. Hill]
  • Clinical implications of pharmacogenetics of antidepressants - [Koichi Otani, Kazuo Mihara, Norio Yasui-Furukori, Akihito Suzuki, Tsuyoshi Kondo and Sunao Kaneko]
  • A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression - [S. Kasper and J. P. Olié]
  • Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study - [Eric Michael Kaplan]
  • 7,7,8,8-Tetracyanoquinodimethane as a new derivatization reagent for high-performance liquid chromatography and thin-layer chromatography: rapid screening of plasma for some antidepressants - [Aysel Oztunc, Armagan Onal and S?d?ka Erturk]
  • Carnosine prevents methamphetamine-induced gliosis but not dopamine terminal loss in rats - [David Pubill, Ester Verdaguer, Francesc X. Sureda, Antoni Camins, Mercè Pallàs, Jordi Camarasa and Elena Escubedo]
  • A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder - [Paola Rocca, Valeria Fonzo, Luigi Ravizza, Giuseppe Rocca, Monica Scotta, Enrico Zanalda and Filippo Bogetto]
  • Different distributions of the 5-HT reuptake complex and the postsynaptic 5-HT2A receptors in Brodmann areas and brain hemispheres - [Pilar Rosel, Belén Arranz, Mikel Urretavizcaya, Miguel Oros, Luis San, Julio Vallejo and Miguel Angel Navarro]
  • An open-label dosing study of paroxetine in depressed children and adolescents - [Robert L. Findling, Carolyn Myers, Mary Ann O]
  • Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures - [Vikram K. Yeragani, Vanessa Pesce, Anusha Jayaraman and Steven Roose]
  • Inhibition of vesicular uptake of monoamines by hyperforin - [Netta Roz, Yehuda Mazur, Amiram Hirshfeld and Moshe Rehavi]
  • Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression - [Paola Rocca, Concetta De Leo, Carola Eva, Livio Marchiaro, Anna Maria Milani, Rita Musso, Luigi Ravizza, Enrico Zanalda and Filippo Bogetto]
  • Effect of chronic treatment with milnacipran on sleep architecture in rats compared with paroxetine and imipramine - [D. Gervasoni, E. Panconi, V. Henninot, R. Boissard, B. Barbagli, P. Fort and P. H. Luppi]
  • A comparison of paroxetine versus paroxetine plus amisulpride in the treatment of dysthymic disorder: efficacy and psychosocial outcomes - [Paola Rocca, Livio Marchiaro, Roberta Rasetti, Elisa Rivoira and Filippo Bogetto]
  • Morphine, cocaine and antidepressant induced motivational activity and midbrain dopaminergic neurotransmission - [Paul N Deslandes, David M Pache, Paul Buckland and Robert D.E Sewell]
  • Enzymatic resolution of (±)-trans-4-(4′-fluorophenyl)-6-oxo-piperidin-3-ethyl carboxylate, an intermediate in the synthesis of (?)-Paroxetine - [Jose M. Palomo, Gloria Fernández-Lorente, Cesar Mateo, Roberto Fernández-Lafuente and José M. Guisan]
  • A retrospective analysis of the revocation of prior authorization restrictions and the use of antidepressant medications for treating major depressive disorder - [Jeffrey S. McCombs, Lizheng Shi, Glen L. Stimmel and Thomas W. Croghan]
  • Improved sample preparation for the quantitative analysis of paroxetine in human plasma by stable isotope dilution negative ion chemical ionisation gas chromatography–mass spectrometry - [Hans J?rg Leis, Werner Windischhofer and Günter Fauler]
  • Comparison of the anticholinergic effects of the serotonergic antidepressants, paroxetine, fluvoxamine and clomipramine - [Jun Fujishiro, Taiichiro Imanishi, Kaname Onozawa and Masaki Tsushima]
  • High-performance liquid chromatography–mass spectrometry method for the determination of paroxetine in human plasma - [Zhimeng Zhu and Len Neirinck]
  • The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression - [Dorotea Mück-eler, Nela Pivac, Marina agud, Miro Jakovljevi and Alma Mihaljevi-Pele]
  • Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus - [Rebeca Martinez-Turrillas, Diana Frechilla and Joaquín Del Río]
  • Enzymatic production of (3S,4R)-(?)-4-(4′-fluorophenyl)-6-oxo-piperidin-3-carboxylic acid using a commercial preparation from Candida antarctica A: the role of a contaminant esterase - [Jose M. Palomo, Gloria Fernández-Lorente, Cesar Mateo, Manuel Fuentes, Jose M. Guisan and Roberto Fernández-Lafuente]
  • Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation - [Juza Chen, Nicola J. Mabjeesh, Haim Matzkin and Alexander Greenstein]
  • Influence of antidepressants on intracellular levels of cyclic adenosine monophosphate in human peripheral blood mononuclear cells - [Gunter Kenis, Harry Steinbusch, Marc De Baets and Michael Maes]
  • Cerebral blood volume and clinical changes on the third day of placebo substitution for SSRI treatment - [Michael E. Henry, Marc J. Kaufman, John Hennen, David Michelson, Mark E. Schmidt, Eve Stoddard, Alexander J. Vukovic, Paul J. Barreira, Bruce M. Cohen and Perry F. Renshaw]
  • Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity - [Gregers Wegener, Vallo Volke, Brian H. Harvey and Raben Rosenberg]
  • Fox odour affects corticosterone release but not hippocampal serotonin reuptake and open field behaviour in rats - [Danusa Dias Soares, Francesca Fernandez, Sylvie Aguerre, Aline Foury, Pierre Mormède and Francis Chaouloff]
  • Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review - [Meera Vaswani, Farzana Kadar Linda and Subramanyam Ramesh]
  • Strain-dependent modification of behavior following antidepressant treatment - [Shanaz Tejani-Butt, Joseph Kluczynski and William P. Paré]
  • Effects of Hypericum perforatum and paroxetine in the mouse defense test battery - [Vanessa Beijamini and Roberto Andreatini]
  • Chronic paroxetine infusion influences macronutrient selection in male Sprague–Dawley rats - [A. T. M. Konkle, K. B. Sreter, S. L. Baker and C. Bielajew]
  • Differential effect of dietary selenium on the long-term neurotoxicity induced by MDMA in mice and rats - [V. Sanchez, J. Camarero, E. O’Shea, A. R. Green and M. I. Colado]
  • Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT2C receptor responsivity - [E. J. Bull, P. H. Hutson and K. C. F. Fone]
  • Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine - [Robert D. Nebes, Bruce G. Pollock, Patricia R. Houck, Meryl A. Butters, Benoit H. Mulsant, Michelle D. Zmuda and Charles F. Reynolds]
  • Mirtazapine for Pruritus - [Mellar P. Davis, Jan L. Frandsen, Declan Walsh, Steven Andresen and Sandy Taylor]
  • Platelet counts in depressed patients treated with amitriptyline or paroxetine - [F. Lederbogen, E. H?rer, R. Hellweg, I. Heuser and M. Deuschle]
  • Serotonin transporter gene polymorphisms and platelet [3H] paroxetine binding in premenstrual dysphoria - [J. Melke, L. Westberg, M. Landén, C. Sundblad, O. Eriksson, F. Baghei, R. Rosmond, E. Eriksson and A. Ekman]
  • Serotonergic activity measured by platelet [3H]paroxetine binding in patients with eating disorders - [Carla E. Ramacciotti, Elisabetta Coli, Riccardo Paoli, Donatella Marazziti and Liliana Dell]
  • Tail-suspension induced hyperthermia: a new measure of stress reactivity - [Xiaoqing Liu, Dorothy Peprah and Howard K. Gershenfeld]
  • Neurosteroid secretion in panic disorder - [Francesca Brambilla, Giovanni Biggio, Maria Giuseppina Pisu, Laura Bellodi, Giampaolo Perna, Vesna Bogdanovich-Djukic, Robert H. Purdy and Mariangela Serra]
  • Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder - [Giuseppina D]
  • Bi-phasic change in BDNF gene expression following antidepressant drug treatment - [A. L. Coppell, Q. Pei and T. S. C. Zetterstr?m]
  • Effect of different 5-HT1A receptor antagonists in combination with paroxetine on expression of the immediate–early gene Arc in rat brain - [R. Tordera, Q. Pei, M. Newson, K. Gray, M. Sprakes and T. Sharp]
  • The bioequivalence and therapeutic efficacy of generic versus brand-name psychoative drugs - [Giuseppe Borgheini]
  • Synthesis of the major metabolites of Paroxetine - [Mireia Segura, Lidia Roura, Rafael de la Torre and Jesús Joglar]
  • Enzymatic alkoxycarbonylation reactions on the intermediate in the synthesis of (?)-paroxetine, trans-N-benzyloxycarbonyl-4-(4′-fluorophenyl)-3-hydroxymethylpiperidine - [Gonzalo de Gonzalo, Rosario Brieva, Víctor M. Sánchez, Miguel Bayod and Vicente Gotor]
  • A reported case involving impaired driving following self-administration of xylazine - [Matthew E. Stillwell]
  • Troubles dysphoriques prémenstruels : diagnostic et traitements médicamenteuxPremenstrual dysphoric disorder: diagnostic and pharmacological treatment - [G. Benjelloun and A. Pelissolo]
  • The biological treatment of dangerous sexual offenders: A review and preliminary report of the Oregon pilot depo-Provera program - [Barry M. Maletzky and Gary Field]
  • Enantioselective synthesis of 3-substituted-4-aryl piperidines useful for the preparation of paroxetine - [K. S. Keshava Murthy, Allan W. Rey and Michael Tjepkema]
  • Dopamine depletion abolishes apomorphine- and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats: a microdialysis study - [A. Balcioglu, K. Zhang and F. I. Tarazi]
  • Selective serotonin reuptake inhibitors combined with venlafaxine in depressed patients who had partial response to venlafaxine: four cases - [Ali Saffet Gonul, Fisun Akdeniz, Ozlem Donat and Simavi Vahip]
  • Determination of paroxetine in geriatric depression by high-performance liquid chromatography - [Isis A. Zainaghi, Vera L. Lanchote and Regina H. C. Queiroz]
  • Effects of Hypericum perforatum and paroxetine on rat performance in the elevated T-maze - [Venessa Beijamini and Roberto Andreatini]
  • Pindolol and the acceleration of the antidepressant response - [Per Plenge and Erling T. Mellerup]
  • Antidepressant-like effects in various mice strains in the tail suspension test - [Nadège Ripoll, Denis Joseph Paul David, Eric Dailly, Martine Hasco?t and Michel Bourin]
  • Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring - [Christine Frahnert, Marie Luise Rao and Katja Grasm?der]
  • Short- and long-term effects of MDMA (“ecstasy”) on synaptosomal and vesicular uptake of neurotransmitters in vitro and ex vivo - [Inger Lise Bogen, Kristin Huse Haug, Oddvar Myhre and Frode Fonnum]
  • Serotonin transporter and MAO-B levels in monoamine nuclei of the human brainstem are normal in major depression - [Violetta Klimek, Gary Roberson, Craig A. Stockmeier and Gregory A. Ordway]
  • Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus - [Glenn W. Kaatz, Varsha V. Moudgal, Susan M. Seo, John Bondo Hansen and Jette E. Kristiansen]
  • Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study - [Marc J. Kaufman, Michael E. Henry, Blaise deB. Frederick, John Hennen, Rosemond A. Villafuerte, Eve P. Stoddard, Mark E. Schmidt, Bruce M. Cohen and Perry F. Renshaw]
  • The effects of paroxetine on rat isolated vas deferens - [Ersin Yaris, Murat Kesim, Mine Kadioglu, Nuri Ihsan Kalyoncu, Cunay Ulku and Rasin Ozyavuz]
  • Brain neurosteroid changes after paroxetine administration in mice - [Allon Nechmad, Rachel Maayan, Baruch Spivak, Edward Ramadan, Michael Poyurovsky and Abraham Weizman]
  • D2 dopamine receptor gene polymorphism: paroxetine and social functioning in posttraumatic stress disorder - [Bruce R. Lawford, , Ross McD. Young, Ernest P. Noble, Burnett Kann, Leanne Arnold, John Rowell and Terry L. Ritchie]
  • Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder - [Eric Vermetten, Meena Vythilingam, Steven M. Southwick, Dennis S. Charney and J. Douglas Bremner]
  • The apolipoprotein E 4 allele and antidepressant efficacy in cognitively intact elderly depressed patients - [Greer M. Murphy, Charlotte Kremer, Heidi Rodrigues and Alan F. Schatzberg]
  • Implications of compulsive and impulsive traits for serotonin status in women with bulimia nervosa - [Howard Steiger, Mimi Isra?l, Lise Gauvin, N. M. K. Ng Ying Kin and Simon N. Young]
  • Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-Glycoprotein gene disruption - [Manfred Uhr, Markus T. Grauer and Florian Holsboer]
  • Interferon-alpha–induced changes in tryptophan metabolism: relationship to depression and paroxetine treatment - [Lucile Capuron, Gabriele Neurauter, Dominique L. Musselman, David H. Lawson, Charles B. Nemeroff, Dietmar Fuchs and Andrew H. Miller]
  • Antidepressant drug treatment induces Arc gene expression in the rat brain - [Q. Pei, T. S. C. Zetterstr?m, M. Sprakes, R. Tordera and T. Sharp]
  • Application of the chiral base desymmetrisation of imides to the synthesis of the alkaloid jamtine and the antidepressant paroxetine - [Christopher D. Gill, Daniel A. Greenhalgh and Nigel S. Simpkins]
  • Aging, estradiol and time of day differentially affect serotonin transporter binding in the central nervous system of female rats - [Kristine Krajnak, Katherine L. Rosewell, Marilyn J. Duncan and Phyllis M. Wise]
  • Thyroid hormones in the rat amygdala as common targets for antidepressant drugs, mood stabilizers, and sleep deprivation - [Graziano Pinna, Oliver Broedel, Murat Eravci, Gisela Stoltenburg-Didinger, Hanna Plueckhan, Sandra Fuxius, Harald Meinhold and Andreas Baumgartner]
  • Regioselective reduction of N-alkyl-3-sulfonyl glutarimides to δ-lactams. Formal synthesis of (±)-paroxetine and (±)-tacamonine - [Chung-Yi Chen, Bo-Rui Chang, Min-Ruei Tsai, Meng-Yang Chang and Nein-Chen Chang]
  • Enantiomeric separation of the key intermediate of paroxetine using chiral chromatography - [V. V. Vivekanand, V. Ravi Kumar, Pradeep K. Mohakhud and G. Om Reddy]
  • Effect of nortriptyline and paroxetine on measures of chaos of heart rate time series in patients with panic disorder - [Vikram Kumar Yeragani and Radhakrishna Rao]
  • Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial - [Zbigniew Zylicz, Malgorzata Krajnik, Adriaan Alistar van Sorge and Massimo Costantini]
  • Good treatment outcomes in late-life depression with comorbid anxiety - [Eric J. Lenze, Benoit H. Mulsant, Mary Amanda Dew, M. Katherine Shear, Patricia Houck, Bruce G. Pollock and Charles F. Reynolds]
  • Serotonin and its transporter on proliferation of fetal heart cells - [Youssef Sari and Feng C. Zhou]
  • HAB/LAB rats: an animal model of extremes in trait anxiety and depression - [Rainer Landgraf]
  • Measurement of total mirtazapine and normirtazapine in plasma/serum by liquid chromatography with fluorescence detection - [P. E. Morgan, J. Tapper and E. P. Spencer]
  • Paroxetine alters KCl- or ATP-induced contractile responses of isolated vas deferens in rats chronically treated with ethanol - [Murat Kesim, Mine Kadioglu, Ersin Yaris, Nuri Ihsan Kalyoncu, Rasin Ozyavuz and Cunay Ulku]


    • 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 [24] 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
    41 42 43 44 45 46 47 48 49 50